The epidemiology of skin cancer: Concern for the care;De epidemiologie van huidkanker: Zorg om de zorg

Nederlands Tijdschrift voor Dermatologie en Venereologie

Volumn 19, Issue 8, 2009, Pages 451-455

  Holterhues, C ^a   De Vries, E ^a   Nijsten, T ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

Author keywords

Basal cell carcinoma; Epidemiology; Melanoma; Skin cancer; Squamous cell carcinoma

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CHEMOPROPHYLAXIS; HEALTH CARE; HUMAN; NETHERLANDS; PATIENT CARE; POPULATION RISK; REVIEW; RISK FACTOR; SKIN BASAL CELL CARCINOMA; SKIN CANCER; SKIN MELANOMA; SKIN SQUAMOUS CELL CARCINOMA; SKIN TRANSPLANTATION; WORKLOAD;

EID: 78249250319     PISSN: 09258604     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Vries E de, Nijsten T, Louwman M, Coebergh JW. Feiten en cijfers achter de huidkankerepidemie. Ned Tijdschr Geneeskd. Geaccepteerd voor publicatie.
2. Vries E de, Nijsten T, Karim-Kos H, Louwman M, Coebergh JW, Poll-Franse LV van de. Observed skin cancer incidence strongly exceed predicted rates in the Netherlands. submitted, 2009.
3. Kiiski V, Vries E de, Bijl MJ, Stricker B, Nijsten T. Risk factor profiles differ between patients with one and multiple basal cell carcinomas: results from the Rotterdam study. submitted, 2009.
4. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Archives of Dermatology 2000;136:1524-30.
5. Bivens MM, Bhosle M, Balkrishnan R, Camacho FT, Feldman SR, Fleischer AB, Jr. Nonmelanoma skin cancer: is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data. Dermatol Surg 2006;32:1473-9.
6. Brewster DH, Bhatti LA, Inglis JH, Nairn ER, Doherty VR. Recent trends in incidence of non-melanoma skin cancers in the East of Scotland, 1992-2003. The British Journal of Dermatology 2007;156:1295-300.
7. Vries E de, Houterman S, Janssen-Heijnen ML, et al. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol 2007;18:1110-6.
8. Hattem S van, Aarts MJ, Louwman WJ, et al. Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in the Netherlands. The British Journal of Dermatology 2009.
9. Hertog SA de, Wensveen CA, Bastiaens MT, et al. Relation between smoking and skin cancer. J Clin Oncol 2001;19:231-8.
10. Kyrgidis A, Tzellos TG, Vahtsevanos K, Triaridis S. New concepts for basal cell carcinoma. Demographic, clinical, histological risk factors, and biomarkers. A systematic review of evidence regarding risk for tumor development, susceptibility for second primary and recurrence. The Journal of Surgical Research 2008.
11. Hoen M 't, Nijsten T. Epidemiologie van het plaveiselcelcarcinoom. Ned Tijdschr Dermatol Venereol 2006;16:380-3.
12. Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene 2003;22:3042-52.
13. Brantsch KD, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. The Lancet Oncology 2008;9:713-20.
14. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007;33:885-99.
15. Vries E de, Nijsten TE, Visser O, et al. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 2008;19:583-9.
16. Kasparian NA, McLoone JK, Meiser B. Skin cancer-related prevention and screening behaviors: a review of the literature. Journal of Behavioral Medicine 2009.
17. Wright TI, Spencer JM, Flowers FP. Chemoprevention of nonmelanoma skin cancer. Journal of the American Academy of Dermatology 2006;54:933-46; quiz 47-50.
18. Graaf YG de, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004;30:656-61.
19. Francis SO, Mahlberg MJ, Johnson KR, Ming ME, Dellavalle RP. Melanoma chemoprevention. Journal of the American Academy of Dermatology 2006;55:849-61.
20. Francken AB, Thompson JF, Bastiaannet E, Hoekstra HJ. Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient followup. Nederlands tijdschrift voor geneeskunde. 2008;152:557-62.